(5R)-5-[(Z)-hex-4-en-2-ynyl]oxolan-2-one

Details

Top
Internal ID e66bd495-e631-4a74-a161-d1501b00c749
Taxonomy Organoheterocyclic compounds > Lactones > Gamma butyrolactones
IUPAC Name (5R)-5-[(Z)-hex-4-en-2-ynyl]oxolan-2-one
SMILES (Canonical) CC=CC#CCC1CCC(=O)O1
SMILES (Isomeric) C/C=C\C#CC[C@H]1CCC(=O)O1
InChI InChI=1S/C10H12O2/c1-2-3-4-5-6-9-7-8-10(11)12-9/h2-3,9H,6-8H2,1H3/b3-2-/t9-/m0/s1
InChI Key QHKZTHGUDZNKEB-XADBCAIWSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C10H12O2
Molecular Weight 164.20 g/mol
Exact Mass 164.083729621 g/mol
Topological Polar Surface Area (TPSA) 26.30 Ų
XlogP 2.00
Atomic LogP (AlogP) 1.66
H-Bond Acceptor 2
H-Bond Donor 0
Rotatable Bonds 1

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (5R)-5-[(Z)-hex-4-en-2-ynyl]oxolan-2-one

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9952 99.52%
Caco-2 + 0.6622 66.22%
Blood Brain Barrier + 0.7500 75.00%
Human oral bioavailability - 0.5000 50.00%
Subcellular localzation Plasma membrane 0.5240 52.40%
OATP2B1 inhibitior - 0.8551 85.51%
OATP1B1 inhibitior + 0.8690 86.90%
OATP1B3 inhibitior + 0.9474 94.74%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.7500 75.00%
BSEP inhibitior - 0.8473 84.73%
P-glycoprotein inhibitior - 0.9836 98.36%
P-glycoprotein substrate - 0.9396 93.96%
CYP3A4 substrate - 0.5539 55.39%
CYP2C9 substrate - 0.8223 82.23%
CYP2D6 substrate - 0.8685 86.85%
CYP3A4 inhibition - 0.8876 88.76%
CYP2C9 inhibition - 0.8399 83.99%
CYP2C19 inhibition - 0.6452 64.52%
CYP2D6 inhibition - 0.9544 95.44%
CYP1A2 inhibition - 0.7234 72.34%
CYP2C8 inhibition - 0.9280 92.80%
CYP inhibitory promiscuity - 0.7309 73.09%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.8428 84.28%
Carcinogenicity (trinary) Non-required 0.5809 58.09%
Eye corrosion + 0.7834 78.34%
Eye irritation - 0.5160 51.60%
Skin irritation - 0.5962 59.62%
Skin corrosion - 0.9425 94.25%
Ames mutagenesis - 0.6137 61.37%
Human Ether-a-go-go-Related Gene inhibition - 0.5832 58.32%
Micronuclear - 0.9200 92.00%
Hepatotoxicity + 0.6963 69.63%
skin sensitisation - 0.5660 56.60%
Respiratory toxicity - 0.6667 66.67%
Reproductive toxicity - 0.6667 66.67%
Mitochondrial toxicity - 0.7500 75.00%
Nephrotoxicity + 0.4582 45.82%
Acute Oral Toxicity (c) III 0.7829 78.29%
Estrogen receptor binding - 0.9031 90.31%
Androgen receptor binding - 0.9234 92.34%
Thyroid receptor binding - 0.8007 80.07%
Glucocorticoid receptor binding - 0.7231 72.31%
Aromatase binding - 0.7686 76.86%
PPAR gamma - 0.6507 65.07%
Honey bee toxicity - 0.8536 85.36%
Biodegradation + 0.5750 57.50%
Crustacea aquatic toxicity + 0.6200 62.00%
Fish aquatic toxicity + 0.6633 66.33%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 89.41% 91.11%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 88.32% 95.56%
CHEMBL2581 P07339 Cathepsin D 86.33% 98.95%
CHEMBL3137262 O60341 LSD1/CoREST complex 83.71% 97.09%
CHEMBL1994 P08235 Mineralocorticoid receptor 81.87% 100.00%

Cross-Links

Top
PubChem 162852891
LOTUS LTS0252404
wikiData Q27145347